Signatur Biosciences makes precision diagnostics more accessible, starting by bringing breast cancer testing within reach for women around the world.
Signatur Biosciences has raised €6.2M across 1 funding round from 3 investors, most recently a round in May 2025. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-22 | Other |
| €6.2M |
| Noshaq,strategic backers,The Discovery Lab of IBA |
| View deal → |
